Both AHR and CTRE operate in the healthcare real estate sector, yet they pursue meaningfully different growth models. This stock comparison is relevant for investors evaluating how two fast-growing healthcare REITs are positioned amid shifting interest rates, an aging population, and active acquisition pipelines. One is a senior-housing operator capturing upside directly, while the other is a net-lease landlord diversifying internationally. Understanding their relative performance, capital structures, and momentum helps traders and longer-term investors weigh market positioning — and assess which name currently presents the stronger risk-adjusted setup.
American Healthcare REIT (AHR) owns and operates a diversified healthcare portfolio spanning senior housing operating properties (SHOP), integrated senior health campuses under its Trilogy platform, outpatient medical buildings, and triple-net leased assets. Its operating model is the centerpiece of the story, allowing the company to capture revenue and margin upside directly rather than relying solely on fixed rents.
Recent market activity has been notably supportive. The company reported third-quarter normalized funds from operations (NFFO) of $0.58 per share, beating consensus, and extended its streak of double-digit same-store NOI growth to 11 straight quarters. SHOP same-store NOI growth accelerated to 28.2%, while total portfolio NOI grew 13.8%. Management raised full-year NFFO guidance to a range of $2.23–$2.26, its third increase of the year, and reduced net debt-to-EBITDA (a leverage measure comparing debt to earnings before interest, taxes, depreciation, and amortization) to about 1.9x. The shares have outperformed the broader market this year, and analyst consensus remains a "Strong Buy" with an average price target well above recent trading levels. That said, meaningful share issuance to fund roughly $2 billion in completed investments introduces some dilution that investors are weighing against accelerating per-share growth.
CareTrust REIT (CTRE) is a self-administered REIT that owns, acquires, and leases skilled nursing, seniors housing, and other healthcare properties, primarily through long-term triple-net leases. It has historically maintained low leverage and a strong balance sheet, which has supported an aggressive acquisition program.
Fundamentally, the company has delivered accelerating results. Third-quarter normalized FFO reached $0.54 per share, up 20% year over year, and management raised full-year guidance for the fourth time. Year-to-date investments have climbed to roughly $2.9 billion, headlined by a partnership to acquire 45 newly built U.K. care homes. Despite this, the stock has experienced a notable pullback in recent weeks, trading below its 200-day moving average as investors weighed lower blended deal yields, rising leverage, and a series of equity offerings — including a roughly $637.5 million common stock offering priced this month. The dividend yield near 4% and a "Buy" consensus provide a measure of support, but near-term sentiment has cooled relative to the company's operating momentum.
Tickeron's Trending AI Robots page curates a selection of automated trading strategies from a broader universe of hundreds of AI trading bots that monitor thousands of different tickers. These bots operate across varying styles, timeframes, and performance profiles, each tailored to a distinct set of securities and market conditions. Rather than showcasing every available bot, the section highlights only those strategies judged most suitable for the current market environment, giving traders a focused view of where algorithmic conviction is currently strongest. Whether you are evaluating momentum, trend-following, or swing-trading approaches, exploring the Trending AI Robots page can help you see how data-driven systems are positioning across the market today.
The clearest contrast between the two names lies in their business models. AHR derives much of its growth from operating senior housing, capturing margin expansion directly as occupancy and pricing improve. CTRE, by comparison, is predominantly a triple-net landlord whose tenants bear operating risk, while the company expands its asset base through acquisitions and a new U.K. foothold.
Growth drivers also differ. AHR's momentum is anchored in same-store NOI acceleration and disciplined pricing, with an acquisition pipeline exceeding $1 billion. CTRE's growth is more external, driven by a record investment pace, though blended yields have edged lower and leverage has crept upward. On market sentiment, AHR has enjoyed favorable price action and estimate revisions, while CTRE faces a disconnect between strong earnings and negative price reaction tied to dilution concerns. Risk factors for AHR include operator execution and share issuance; for CTRE, they center on integration of the U.K. platform and financing-related overhang.
Based on observable trend consistency, relative strength, and market positioning, Tickeron's AI would currently favor AHR. The stock has sustained a steadier uptrend, delivered repeated upward guidance revisions supported by organic same-store growth, and maintained a stronger analyst consensus with meaningful upside to average price targets. While CTRE shows impressive fundamental acceleration, its recent price action and financing-related sentiment shift suggest less favorable short-term positioning. These conditions give AHR a probabilistic edge at present, though the balance could shift as either company's catalysts and capital markets evolve.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Stochastic Oscillator for AHR moved out of overbought territory on November 19, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 40 similar instances where the indicator exited the overbought zone. In 25 of the 40 cases the stock moved lower. This puts the odds of a downward move at 62%.
The 10-day RSI Indicator for AHR moved out of overbought territory on November 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 16 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 62%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AHR as a result. In 28 of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
The Moving Average Convergence Divergence Histogram (MACD) for AHR turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 25 similar instances when the indicator turned negative. In 15 of the 25 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
AHR broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
AHR moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AHR crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 33%.
Following a +2.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where AHR advanced for three days, in 155 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 142 of 221 cases where AHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. AHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.417) is normal, around the industry mean (3.134). P/E Ratio (83.928) is within average values for comparable stocks, (30.791). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.649). Dividend Yield (0.023) settles around the average of (0.050) among similar stocks. P/S Ratio (3.877) is also within normal values, averaging (6.013).
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.
The Aroon Indicator for CTRE entered a downward trend on October 19, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 146 similar instances where the Aroon Indicator formed such a pattern. In 84 of the 146 cases the stock moved lower. This puts the odds of a downward move at 58%.
The Momentum Indicator moved below the 0 level on November 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTRE as a result. In 36 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.
The Moving Average Convergence Divergence Histogram (MACD) for CTRE turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 18 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 38%.
CTRE moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
CTRE broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for CTRE crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +4.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTRE advanced for three days, in 217 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. CTRE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.010) is normal, around the industry mean (3.134). P/E Ratio (23.881) is within average values for comparable stocks, (30.791). Projected Growth (PEG Ratio) (0.370) is also within normal values, averaging (1.649). Dividend Yield (0.041) settles around the average of (0.050) among similar stocks. CTRE's P/S Ratio (18.762) is very high in comparison to the industry average of (6.013).
CTRE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 8 | |
SMR RATING 1..100 | 74 | |
PRICE GROWTH RATING 1..100 | 55 | |
P/E GROWTH RATING 1..100 | 61 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AHR | CTRE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 62% | N/A |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 57% | 2 days ago 44% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 38% |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 51% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 63% |
| Advances ODDS (%) | 12 days ago 76% | 13 days ago 67% |
| Declines ODDS (%) | 2 days ago 55% | 2 days ago 49% |
| BollingerBands ODDS (%) | 2 days ago 48% | 2 days ago 38% |
| Aroon ODDS (%) | 2 days ago 64% | 4 days ago 58% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AHR’s FA Score shows that 0 FA rating(s) are green while CTRE’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AHR’s TA Score shows that 4 TA indicator(s) are bullish while CTRE’s TA Score has 3 bullish TA indicator(s).
AHR (@Publishing: Books/Magazines) experienced а -0.42% price change this week, while CTRE (@Publishing: Books/Magazines) price change was -3.47% for the same time period.
The average weekly price growth across all stocks in the @Publishing: Books/Magazines industry was -1.84%. For the same industry, the average monthly price growth was +0.08%, and the average quarterly price growth was -6.30%.
CTRE is expected to report earnings on Feb 11, 2027.
The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.
A.I.dvisor indicates that over the last year, AHR has been closely correlated with WELL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if AHR jumps, then WELL could also see price increases.
| Ticker / NAME | Correlation To AHR | 1D Price Change % | ||
|---|---|---|---|---|
| AHR | 100% | -0.12% | ||
| WELL - AHR | 73% Closely correlated | -1.17% | ||
| VTR - AHR | 71% Closely correlated | -0.52% | ||
| OHI - AHR | 68% Closely correlated | -0.85% | ||
| SBRA - AHR | 64% Loosely correlated | -0.34% | ||
| CTRE - AHR | 64% Loosely correlated | -0.73% | ||
More | ||||
A.I.dvisor indicates that over the last year, CTRE has been closely correlated with OHI. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if CTRE jumps, then OHI could also see price increases.
| Ticker / NAME | Correlation To CTRE | 1D Price Change % | ||
|---|---|---|---|---|
| CTRE | 100% | -0.73% | ||
| OHI - CTRE | 81% Closely correlated | -0.85% | ||
| SBRA - CTRE | 73% Closely correlated | -0.34% | ||
| AHR - CTRE | 72% Closely correlated | -0.12% | ||
| LTC - CTRE | 68% Closely correlated | +0.24% | ||
| NHI - CTRE | 68% Closely correlated | -0.28% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PAAA | 51.46 | 0.03 | +0.06% |
| PGIM AAA CLO ETF (PAAA) | |||
| OUSA | 61.30 | -0.59 | -0.95% |
| ALPS O'Shares U.S. Quality Dividend ETF (OUSA) | |||
| DAX | 41.71 | -1.26 | -2.93% |
| Global X DAX Germany ETF (DAX) | |||
| EDGQ | 22.75 | -1.45 | -6.00% |
| Global X Nasdaq-100 Income Edge ETF (EDGQ) | |||
| SNDU | 2.62 | -1.21 | -31.59% |
| T-REX 2X Long SNDK Daily Target ETF (SNDU) | |||